Eris Lifesciences working on $200m IPO plans, ChrysCapital may exit

Eris Lifesciences working on $200m IPO plans, ChrysCapital may exit

Visual from the Eris company website. Company's manufacturing plant

Swaraj Singh Dhanjal

10 October, 2016

ChrysCapitalEris Lifesciences Pvt. Ltd

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2026 All rights reserved.